Peer review reports
From: Randomized phase III trial of APF530 versus palonosetron in the prevention of chemotherapy-induced nausea and vomiting in a subset of patients with breast cancer receiving moderately or highly emetogenic chemotherapy
Original Submission |
13 Apr 2015 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
|
Reviewed |
Reviewer Report
|
|
Reviewed |
Reviewer Report
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
|
Reviewed |
Reviewer Report
|
Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
Publishing |
16 Feb 2016 |
Editorially accepted |
|
26 Feb 2016 |
Article published |
10.1186/s12885-016-2186-4
|
Learn about peer review